Cerus Corporation announced the appointment of Hua Shan, MD, PhD, Professor of Pathology and Medical Director, Transfusion Medicine Service at Stanford Medical Center to its Board of Directors. Prior to her roles at Stanford, Dr. Shan served as the Medical Director of the Blood Bank Service and as the Associate Director of Transfusion Medicine at Johns Hopkins University, Assistant Medical Director at Medical University of South Carolina and Transfusion Medicine Fellow at the University of Pennsylvania. Company expect to benefit from Dr. Shan's expertise as company continue to work toward bringing the INTERCEPT Blood System to China's transfusion medicine community through the joint venture.

As Cerus continues to grow its global presence as a leading provider of therapeutic solutions to increase blood product safety and availability while enabling patient access, company believe the addition of Dr. Shan will provide us with invaluable perspective and company look forward to her many contributions to the organization.